How to buy PYC Therapeutics shares | A$0.175

PYC Therapeutics Limited is a biotechnology business based in Australia. PYC Therapeutics shares (PYC) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.175 – a decrease of 5.41% over the previous week. PYC Therapeutics has a trailing 12-month revenue of around $62,500.

How to buy shares in PYC Therapeutics

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for PYC Therapeutics . Find the share by name or ticker symbol: PYC. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PYC Therapeutics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $0.175, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of PYC Therapeutics . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted PYC Therapeutics 's share price?

Since the stock market crash in March caused by coronavirus, PYC Therapeutics 's share price has had significant positive movement.

Its last market close was $0.175, which is 60.57% up on its pre-crash value of $0.069 and 306.98% up on the lowest point reached during the March crash when the shares fell as low as $0.043.

If you had bought $1,000 worth of PYC Therapeutics shares at the start of February 2020, those shares would have been worth $827.59 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $3,017.24.

PYC Therapeutics share price

Use our graph to track the performance of PYC stocks over time.

PYC Therapeutics shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	AUDA$0.175
52-week range	AUDA$0.043 - AUDA$0.205
50-day moving average	AUDA$0.155
200-day moving average	AUDA$0.1137
Target price	AUDA$0.02
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.002

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy PYC Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of PYC Therapeutics Limited by TradingView

PYC Therapeutics price performance over time

Historical closes compared with the close of A$0.175 on 2020-10-22

1 week (2020-10-23)	0%
1 month (2020-10-01)	9.37%
3 months (2020-07-31)	52.17%
6 months (2020-05-01)	133.33%

1 year (2019-10-30)	187.83%
2 years (2018-10-31)	423.95%
3 years (2017-10-31)	369.17%
5 years (2015-10-30)	1,383.05%

PYC Therapeutics financials

Revenue TTM	$62,500
Gross profit TTM	$-2,340,474
Return on assets TTM	-31.5%
Return on equity TTM	-38.8%
Profit margin	0%
Book value	0.01
Market capitalisation	$542.3 million

TTM: trailing 12 months

PYC Therapeutics share dividends

We're not expecting PYC Therapeutics to pay a dividend over the next 12 months.

PYC Therapeutics share price volatility

Over the last 12 months, PYC Therapeutics 's shares have ranged in value from as little as $0.043 up to $0.205. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while PYC Therapeutics 's is 0.9292. This would suggest that PYC Therapeutics 's shares are less volatile than average (for this exchange).

PYC Therapeutics overview

PYC Therapeutics Limited provides drug discovery services utilizing peptide libraries and proprietary screening capabilities in Australia. The company provides next generation delivery platform for cell-penetrating peptides (CPPs), a small biological molecule. The company's proprietary peptide libraries contain fragments from diverse and evolutionarily distinct microbial genomes - organisms which known as cell-penetrating properties. It develops CPP- Antisense Oligonucleotides (ASOs), a pipeline of drugs for the treatment of retinal disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

Frequently asked questions

• What percentage of PYC Therapeutics is owned by insiders?

  Currently 64.144% of PYC Therapeutics shares are held by insiders.

• When does the fiscal year end for PYC Therapeutics ?

  PYC Therapeutics 's fiscal year ends in June.

• Where is PYC Therapeutics based?

  PYC Therapeutics 's address is: Harry Perkins Institute of Medical Resea, Nedlands, WA, Australia, 6009

• What is PYC Therapeutics 's ISIN number?

  PYC Therapeutics 's international securities identification number is: AU000000PYC7